World Population Profile: 1996
Population Projections Incorporating AIDS
Background
Although it has been clear for a number of years that mortality estimates and projections for
many countries would have to be revised due to AIDS mortality, the lack of accurate empirical
data on AIDS deaths, the paucity of data on HIV infection among the general population, and the
absence of tools to project the impact of AIDS epidemics into the future have all hampered these
efforts. Although the accuracy of data on AIDS deaths has not substantially improved,
knowledge of HIV infection has expanded and modeling tools have become available to project
current epidemics into the future.
The methodology used to project AIDS mortality for this report generally follows the method
adopted for World Population Profile: 1994, with several modifications. The method consists of
the following steps:
1. Establish criteria for selecting countries for which AIDS mortality will be incorporated into
the projections.
2. For each selected country, determine the empirical epidemic trend and a point estimate of
national HIV prevalence.
3. Model the spread of HIV infection and the development of AIDS in the population, generating
alternative epidemic scenarios, and produce the seroprevalence rates and AIDS-related age-specific mortality rates which correspond to each epidemic scenario.
4. Use the empirical levels and trends (from step 2) to establish a factor representing each
country's position on a continuum between high and low epidemics (from step 3). Use the
derived factor to generate a unique interpolated epidemic.
5. Use weighted country total adult seroprevalence to determine an appropriate location on the
total country epidemic curve implied by the interpolation factor. This projects adult HIV
seroprevalence for the total country.
6. Interpolate AIDS-related mortality rates, by age and sex, associated with the estimated speed
and level of HIV from epidemic results for the period 1990 to 2010.
In the sections that follow, each of these steps is described, and the method is illustrated.
Country Selection Criteria
The International Programs Center (Population Division, Bureau of the Census) maintains an
HIV/AIDS Surveillance Data Base. This data base is a compilation of aggregate data from HIV
seroprevalence studies in developing countries. Currently, it contains over 25,000 data items
drawn from nearly 3,200 publications and presentations. As a part of the updating of the data
base, new data are reviewed for inclusion into a summary table which, for each country, lists the
most recent and best study of seroprevalence levels for high- and low-risk populations in urban
and rural areas. (Note: High risk includes samples of prostitutes and their clients, sexually-transmitted disease patients, or other persons with known risk factors. Low risk includes samples
of pregnant women, volunteer blood donors, or others with no known risk factors. For a more
complete description of the selection criteria, see U.S. Bureau of the Census (1995).)
A review of the data in the summary table suggests that a reasonable cut-off point for selection
would be countries that have reached 5 percent HIV prevalence among their low-risk urban
populations or, based on recent trends, appear to be likely to reach this level in the near future.
A total of 21 countries now meet these criteria for the incorporation of AIDS mortality in the
projections. All but two of these countries are in Africa. The countries are:
- Botswana
- Burkina Faso
- Burundi
- Cameroon
- Central African Republic
- Congo
- Côte d'Ivoire
- Ethiopia
- Guyana
- Haiti
- Kenya
- Lesotho
- Malawi
- Nigeria
- Rwanda
- South Africa
- Tanzania
- Uganda
- Zaire
- Zambia
- Zimbabwe
AIDS mortality was incorporated into projections for two other countries, Brazil and Thailand,
because some country-specific modeling work had already been completed. The description of
the simplified approach taken in these special cases follows that of the more general procedure.
Empirical Epidemic Trends
For each of the 21 countries meeting the selection criteria, we reviewed the HIV seroprevalence
information available in the HIV/AIDS Surveillance Data Base to establish urban seroprevalence
trends over time (table B-1, cols.1-4) and to identify available rural data points (table B-1, cols.
5-6). The two data points judged to be most representative for the urban low-risk population were
identified and used to calculate the annual change between the dates of the two studies. Rural
data were used in conjunction with the urban data to establish a total-country seroprevalence
estimate (table B-1, col. 7).
Alternative Scenarios
To project the impact in the selected countries, three alternative epidemic scenarios were
developed, corresponding to low, medium, and high-impact AIDS epidemics. These scenarios
were developed using iwgAIDS, which is a complex deterministic model of the spread of HIV
infection and the development of AIDS in a population. It was developed under the sponsorship
of the Interagency Working Group (iwg) on AIDS Models and Methods of the U.S. Department
of State (Stanley et al. 1991).
All three of these epidemic scenarios incorporate increasing levels of behavior change in the
form of increased condom use. This assumption corresponds to actual changes in behavior that
are now beginning to occur in some countries.
Interpolation of a Unique Epidemic
The empirical urban trend from each country was used to interpolate among the three epidemic
scenarios to derive an epidemic trend line matching the observed HIV seroprevalence increase
between two data points. Thus, both the level and the rate of increase of the urban epidemic were
matched through this procedure, resulting in an interpolation factor used in subsequent steps.
Projected Total Seroprevalence
At this point in the estimation procedure, no direct linkage has been made to the total-country
prevalence or to a particular calendar year in this country's epidemic. The next step accomplishes
these tasks. The total-country adult prevalence estimate (table B-1, col. 7) was matched with the
one implied using the interpolation factor. From this comparison, an "offset" figure was
calculated, corresponding to the number of years of difference between the start of the epidemics
in the three scenarios and the empirical epidemic at the reference date.
AIDS-Related Mortality Rates
Based on the "interpolation factor" and the "offset" described above, AIDS-related age-sex-specific mortality rates
( nmx values) at 5-year intervals from 1990 to 2010 were interpolated and
added to non-AIDS nmx values for the same period (non-AIDS nmx values were derived by
making standard assumptions concerning the improvement in mortality conditions as described
earlier in this appendix). Population projections were prepared with the combined nmx values as
input, using the Rural-Urban Projection Program (RUP) of the Bureau of the Census.
The future course of the AIDS pandemic is uncertain, but making projections for affected
countries requires that some assumptions be made about AIDS mortality as well as about non-AIDS mortality. For the projections underlying this report, it was assumed that the epidemics in
each of the 23 affected countries would peak in 2010, with no further growth in HIV infection
after that year. AIDS mortality was assumed to decline from the level reached in 2010 to nil by
2050, thus implying a return to "normal" mortality levels in the latter year. To implement the
projection process, life tables for 2050 that assume no AIDS mortality were used.
The Special Cases of Brazil and Thailand
Modeling activities were also undertaken for Brazil and Thailand with the support of the
Interagency Working Group. AIDS epidemics in these two countries have substantial
homosexual and intravenous drug use components, while those in Africa do not (WHO/GPA
1993). For Brazil, AIDS-related age-sex-specific mortality rates were estimated from the
iwgAIDS model and added directly to the non-AIDS mortality rates previously prepared for the
projection program. For Thailand, AIDS-related mortality rates from recent epidemiological and
demographic projections (TNESDB 1994) were added to the non-AIDS nmx values for the 1990
to 2010 period.
Caveats and Limitations
In developing the methodology for these projections, the International Programs Center has
attempted to maximize the use of both the empirical data and the modeling tools available.
However, there is much that is unknown about the dynamics of AIDS epidemics in countries
around the world, and the methodology is necessarily imprecise. As the AIDS pandemic grows,
future behavior changes and interventions being implemented in countries around the world may
alter the projected course.
What if AIDS epidemics do not peak early in the next century as projected? Will entire
populations become infected with HIV and eventually die from AIDS? The simulations used for
this report suggest that this will not happen in any population, although population declines are
possible with a sustained widespread epidemic. Variations in sexual behavior help to ensure that
the majority of the population in countries around the world are not at high risk of HIV infection.
With substantial proportions of the population at lower risk of infection, each of the epidemic
scenarios displays a definite plateau in HIV seroprevalence after the initial rapid rise.
Source: U.S. Bureau of the Census, World Population Profile: 1996, pp. B-6 to B-10.